menu
    • menu
    [{"orgOrder":0,"company":"HanchorBio","sponsor":"Shanghai Henlius Biotech","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"TAIWAN","productType":"Protein","year":"2025","type":"Licensing Agreement","leadProduct":"HCB101","moa":"CD47-SIRPalpha","graph1":"Oncology","graph2":"Phase I","graph3":"HanchorBio","amount2":0.20000000000000001,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0.20000000000000001,"dosageForm":"Intravenous Infusion","sponsorNew":"HanchorBio \/ Shanghai Henlius Biotech","highestDevelopmentStatusID":"6","companyTruncated":"HanchorBio \/ Shanghai Henlius Biotech"}]

    Find Clinical Drug Pipeline Developments & Deals by HanchorBio

    Menu

    HanchorBio

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            HanchorBio

                            Taiwan arrow
                            CRS
                            Not Confirmed

                            HanchorBio

                            Taiwan arrow
                            CRS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HCB101

                            Therapeutic Area : Oncology

                            Study Phase : Phase I

                            Sponsor : Shanghai Henlius Biotech

                            Deal Size : $202.0 million

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            Henlius pens $202M pact for HanchorBio's midstage CD47 blocker

                            Details : Under the licensing agreement, HanchorBio grants Henlius exclusive development and commercialization rights to HCB101 across Greater China.

                            Product Name : HCB101

                            Product Type : Protein

                            Upfront Cash : $10.0 million

                            July 01, 2025

                            Lead Product(s) : HCB101

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase I

                            Sponsor : Shanghai Henlius Biotech

                            Deal Size : $202.0 million

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth